nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP2C9—brain cancer	0.412	1	CbGaD
Amitriptyline—CYP2D6—Lomustine—brain cancer	0.0352	0.164	CbGbCtD
Amitriptyline—CYP1A2—Carmustine—brain cancer	0.0348	0.162	CbGbCtD
Amitriptyline—CYP2D6—Hydroxyurea—brain cancer	0.0266	0.124	CbGbCtD
Amitriptyline—CYP3A4—Temozolomide—brain cancer	0.0263	0.122	CbGbCtD
Amitriptyline—CYP3A4—Lomustine—brain cancer	0.0224	0.104	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—brain cancer	0.0178	0.0829	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—brain cancer	0.0139	0.0645	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—brain cancer	0.0133	0.062	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—brain cancer	0.0103	0.048	CbGbCtD
Amitriptyline—ABCB1—Etoposide—brain cancer	0.00902	0.0419	CbGbCtD
Amitriptyline—CYP3A4—Etoposide—brain cancer	0.0054	0.0251	CbGbCtD
Amitriptyline—Dysarthria—Lomustine—brain cancer	0.00219	0.02	CcSEcCtD
Amitriptyline—Disorientation—Lomustine—brain cancer	0.00168	0.0154	CcSEcCtD
Amitriptyline—Tongue discolouration—Temozolomide—brain cancer	0.00165	0.015	CcSEcCtD
Amitriptyline—Bone marrow depression—Hydroxyurea—brain cancer	0.00151	0.0138	CcSEcCtD
Amitriptyline—Osteoarthritis—Lomustine—brain cancer	0.0015	0.0137	CcSEcCtD
Amitriptyline—Ataxia—Lomustine—brain cancer	0.00141	0.0129	CcSEcCtD
Amitriptyline—Dysarthria—Procarbazine—brain cancer	0.00139	0.0127	CcSEcCtD
Amitriptyline—Cerebration impaired—Temozolomide—brain cancer	0.00135	0.0124	CcSEcCtD
Amitriptyline—Nightmare—Procarbazine—brain cancer	0.00127	0.0116	CcSEcCtD
Amitriptyline—Pancytopenia—Lomustine—brain cancer	0.00123	0.0113	CcSEcCtD
Amitriptyline—Coma—Procarbazine—brain cancer	0.0012	0.011	CcSEcCtD
Amitriptyline—Gynaecomastia—Procarbazine—brain cancer	0.00118	0.0107	CcSEcCtD
Amitriptyline—Stomatitis—Lomustine—brain cancer	0.00113	0.0103	CcSEcCtD
Amitriptyline—Vascular purpura—Procarbazine—brain cancer	0.00107	0.00975	CcSEcCtD
Amitriptyline—Disorientation—Procarbazine—brain cancer	0.00107	0.00975	CcSEcCtD
Amitriptyline—Extrapyramidal disorder—Temozolomide—brain cancer	0.00106	0.00965	CcSEcCtD
Amitriptyline—Purpura—Procarbazine—brain cancer	0.000991	0.00905	CcSEcCtD
Amitriptyline—Alopecia—Lomustine—brain cancer	0.00092	0.0084	CcSEcCtD
Amitriptyline—Disturbance in attention—Temozolomide—brain cancer	0.000918	0.00838	CcSEcCtD
Amitriptyline—Ataxia—Procarbazine—brain cancer	0.000898	0.0082	CcSEcCtD
Amitriptyline—Coordination abnormal—Carmustine—brain cancer	0.000838	0.00765	CcSEcCtD
Amitriptyline—Disorientation—Hydroxyurea—brain cancer	0.000826	0.00755	CcSEcCtD
Amitriptyline—Hepatic failure—Hydroxyurea—brain cancer	0.000822	0.00751	CcSEcCtD
Amitriptyline—Eosinophilia—Procarbazine—brain cancer	0.000817	0.00746	CcSEcCtD
Amitriptyline—Leukopenia—Lomustine—brain cancer	0.000811	0.0074	CcSEcCtD
Amitriptyline—Coordination abnormal—Temozolomide—brain cancer	0.00081	0.0074	CcSEcCtD
Amitriptyline—Sweating increased—Procarbazine—brain cancer	0.000804	0.00734	CcSEcCtD
Amitriptyline—Tingling sensation—Etoposide—brain cancer	0.000792	0.00723	CcSEcCtD
Amitriptyline—Pancytopenia—Procarbazine—brain cancer	0.000784	0.00716	CcSEcCtD
Amitriptyline—Numbness—Etoposide—brain cancer	0.000768	0.00701	CcSEcCtD
Amitriptyline—Pollakiuria—Procarbazine—brain cancer	0.000763	0.00696	CcSEcCtD
Amitriptyline—Coma—Carmustine—brain cancer	0.000752	0.00687	CcSEcCtD
Amitriptyline—Gynaecomastia—Carmustine—brain cancer	0.000736	0.00673	CcSEcCtD
Amitriptyline—Drowsiness—Procarbazine—brain cancer	0.000736	0.00672	CcSEcCtD
Amitriptyline—Sensory loss—Etoposide—brain cancer	0.000735	0.00671	CcSEcCtD
Amitriptyline—Thrombocytopenia—Lomustine—brain cancer	0.000724	0.00661	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Procarbazine—brain cancer	0.000721	0.00659	CcSEcCtD
Amitriptyline—Stomatitis—Procarbazine—brain cancer	0.000717	0.00655	CcSEcCtD
Amitriptyline—Jaundice—Procarbazine—brain cancer	0.000717	0.00655	CcSEcCtD
Amitriptyline—Mental disability—Carmustine—brain cancer	0.000714	0.00652	CcSEcCtD
Amitriptyline—Anorexia—Lomustine—brain cancer	0.000705	0.00644	CcSEcCtD
Amitriptyline—Mental disability—Temozolomide—brain cancer	0.00069	0.0063	CcSEcCtD
Amitriptyline—Body temperature increased—Carboplatin—brain cancer	0.000668	0.0061	CcSEcCtD
Amitriptyline—Hallucination—Procarbazine—brain cancer	0.000657	0.006	CcSEcCtD
Amitriptyline—Vascular purpura—Temozolomide—brain cancer	0.000645	0.00589	CcSEcCtD
Amitriptyline—Decreased appetite—Lomustine—brain cancer	0.000643	0.00587	CcSEcCtD
Amitriptyline—Hepatic failure—Temozolomide—brain cancer	0.000643	0.00587	CcSEcCtD
Amitriptyline—Pancytopenia—Hydroxyurea—brain cancer	0.000607	0.00554	CcSEcCtD
Amitriptyline—Purpura—Temozolomide—brain cancer	0.000599	0.00547	CcSEcCtD
Amitriptyline—Arrhythmia—Procarbazine—brain cancer	0.00059	0.00539	CcSEcCtD
Amitriptyline—Body temperature increased—Lomustine—brain cancer	0.000584	0.00534	CcSEcCtD
Amitriptyline—Alopecia—Procarbazine—brain cancer	0.000584	0.00533	CcSEcCtD
Amitriptyline—Weight increased—Hydroxyurea—brain cancer	0.000581	0.00531	CcSEcCtD
Amitriptyline—KCND2—medulla oblongata—brain cancer	0.000579	0.0037	CbGeAlD
Amitriptyline—HTR2A—pineal body—brain cancer	0.000574	0.00367	CbGeAlD
Amitriptyline—Drowsiness—Hydroxyurea—brain cancer	0.00057	0.0052	CcSEcCtD
Amitriptyline—HTR7—endothelium—brain cancer	0.000569	0.00364	CbGeAlD
Amitriptyline—Ataxia—Carmustine—brain cancer	0.000562	0.00513	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000558	0.0051	CcSEcCtD
Amitriptyline—Stomatitis—Hydroxyurea—brain cancer	0.000555	0.00507	CcSEcCtD
Amitriptyline—HTR6—telencephalon—brain cancer	0.000548	0.0035	CbGeAlD
Amitriptyline—Ataxia—Temozolomide—brain cancer	0.000543	0.00496	CcSEcCtD
Amitriptyline—Tremor—Procarbazine—brain cancer	0.000539	0.00492	CcSEcCtD
Amitriptyline—KCND2—midbrain—brain cancer	0.000529	0.00338	CbGeAlD
Amitriptyline—OPRD1—telencephalon—brain cancer	0.000529	0.00338	CbGeAlD
Amitriptyline—KCNQ3—head—brain cancer	0.000527	0.00337	CbGeAlD
Amitriptyline—HTR7—blood vessel—brain cancer	0.000525	0.00336	CbGeAlD
Amitriptyline—HTR1A—hindbrain—brain cancer	0.000524	0.00335	CbGeAlD
Amitriptyline—KCND2—spinal cord—brain cancer	0.000516	0.0033	CbGeAlD
Amitriptyline—Syncope—Procarbazine—brain cancer	0.000516	0.00471	CcSEcCtD
Amitriptyline—Leukopenia—Procarbazine—brain cancer	0.000515	0.0047	CcSEcCtD
Amitriptyline—Hallucination—Hydroxyurea—brain cancer	0.000509	0.00465	CcSEcCtD
Amitriptyline—Loss of consciousness—Procarbazine—brain cancer	0.000506	0.00462	CcSEcCtD
Amitriptyline—NTRK2—brain—brain cancer	0.000503	0.00322	CbGeAlD
Amitriptyline—HTR7—hindbrain—brain cancer	0.000501	0.0032	CbGeAlD
Amitriptyline—Convulsion—Procarbazine—brain cancer	0.000498	0.00455	CcSEcCtD
Amitriptyline—Hypertension—Procarbazine—brain cancer	0.000497	0.00453	CcSEcCtD
Amitriptyline—KCNQ2—endocrine gland—brain cancer	0.000491	0.00314	CbGeAlD
Amitriptyline—Pancytopenia—Carmustine—brain cancer	0.00049	0.00448	CcSEcCtD
Amitriptyline—Anxiety—Procarbazine—brain cancer	0.000488	0.00446	CcSEcCtD
Amitriptyline—Sweating increased—Temozolomide—brain cancer	0.000486	0.00444	CcSEcCtD
Amitriptyline—KCNQ2—head—brain cancer	0.000485	0.0031	CbGeAlD
Amitriptyline—ADRA1A—hindbrain—brain cancer	0.000483	0.00309	CbGeAlD
Amitriptyline—KCNQ3—central nervous system—brain cancer	0.000481	0.00307	CbGeAlD
Amitriptyline—Dry mouth—Procarbazine—brain cancer	0.000479	0.00437	CcSEcCtD
Amitriptyline—Pancytopenia—Temozolomide—brain cancer	0.000474	0.00433	CcSEcCtD
Amitriptyline—Confusional state—Procarbazine—brain cancer	0.000473	0.00432	CcSEcCtD
Amitriptyline—DRD2—hindbrain—brain cancer	0.000473	0.00303	CbGeAlD
Amitriptyline—Vomiting—Lomustine—brain cancer	0.00047	0.00429	CcSEcCtD
Amitriptyline—KCNQ3—cerebellum—brain cancer	0.00047	0.003	CbGeAlD
Amitriptyline—Oedema—Procarbazine—brain cancer	0.000469	0.00429	CcSEcCtD
Amitriptyline—KCNA1—midbrain—brain cancer	0.000464	0.00297	CbGeAlD
Amitriptyline—Shock—Procarbazine—brain cancer	0.000462	0.00422	CcSEcCtD
Amitriptyline—KCND3—midbrain—brain cancer	0.000461	0.00295	CbGeAlD
Amitriptyline—Pollakiuria—Temozolomide—brain cancer	0.000461	0.00421	CcSEcCtD
Amitriptyline—Erectile dysfunction—Temozolomide—brain cancer	0.00046	0.0042	CcSEcCtD
Amitriptyline—Thrombocytopenia—Procarbazine—brain cancer	0.00046	0.0042	CcSEcCtD
Amitriptyline—KCND2—head—brain cancer	0.000459	0.00293	CbGeAlD
Amitriptyline—Tachycardia—Procarbazine—brain cancer	0.000458	0.00418	CcSEcCtD
Amitriptyline—Weight increased—Temozolomide—brain cancer	0.000454	0.00415	CcSEcCtD
Amitriptyline—Hyperhidrosis—Procarbazine—brain cancer	0.000454	0.00414	CcSEcCtD
Amitriptyline—KCNA1—spinal cord—brain cancer	0.000453	0.00289	CbGeAlD
Amitriptyline—Alopecia—Hydroxyurea—brain cancer	0.000452	0.00413	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Carmustine—brain cancer	0.000451	0.00412	CcSEcCtD
Amitriptyline—Stomatitis—Carmustine—brain cancer	0.000449	0.0041	CcSEcCtD
Amitriptyline—Anorexia—Procarbazine—brain cancer	0.000447	0.00409	CcSEcCtD
Amitriptyline—KCNQ2—central nervous system—brain cancer	0.000442	0.00283	CbGeAlD
Amitriptyline—Nausea—Lomustine—brain cancer	0.000439	0.00401	CcSEcCtD
Amitriptyline—Hypotension—Procarbazine—brain cancer	0.000439	0.00401	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Temozolomide—brain cancer	0.000436	0.00398	CcSEcCtD
Amitriptyline—Stomatitis—Temozolomide—brain cancer	0.000434	0.00396	CcSEcCtD
Amitriptyline—KCNQ2—cerebellum—brain cancer	0.000432	0.00276	CbGeAlD
Amitriptyline—ADRA1D—telencephalon—brain cancer	0.000428	0.00273	CbGeAlD
Amitriptyline—Insomnia—Procarbazine—brain cancer	0.000425	0.00388	CcSEcCtD
Amitriptyline—Paraesthesia—Procarbazine—brain cancer	0.000421	0.00385	CcSEcCtD
Amitriptyline—KCND2—central nervous system—brain cancer	0.000419	0.00268	CbGeAlD
Amitriptyline—Somnolence—Procarbazine—brain cancer	0.000417	0.00381	CcSEcCtD
Amitriptyline—Ill-defined disorder—Hydroxyurea—brain cancer	0.000413	0.00377	CcSEcCtD
Amitriptyline—HTR2A—ganglion—brain cancer	0.000412	0.00263	CbGeAlD
Amitriptyline—Hypoaesthesia—Carmustine—brain cancer	0.000411	0.00376	CcSEcCtD
Amitriptyline—Hallucination—Carmustine—brain cancer	0.000411	0.00376	CcSEcCtD
Amitriptyline—KCND2—cerebellum—brain cancer	0.000409	0.00262	CbGeAlD
Amitriptyline—Decreased appetite—Procarbazine—brain cancer	0.000408	0.00373	CcSEcCtD
Amitriptyline—OPRM1—brainstem—brain cancer	0.000407	0.0026	CbGeAlD
Amitriptyline—Fatigue—Procarbazine—brain cancer	0.000405	0.0037	CcSEcCtD
Amitriptyline—KCNA1—head—brain cancer	0.000402	0.00257	CbGeAlD
Amitriptyline—Malaise—Hydroxyurea—brain cancer	0.000401	0.00367	CcSEcCtD
Amitriptyline—Constipation—Procarbazine—brain cancer	0.000401	0.00367	CcSEcCtD
Amitriptyline—KCND3—head—brain cancer	0.0004	0.00256	CbGeAlD
Amitriptyline—Hepatitis—Temozolomide—brain cancer	0.000399	0.00365	CcSEcCtD
Amitriptyline—Leukopenia—Hydroxyurea—brain cancer	0.000398	0.00364	CcSEcCtD
Amitriptyline—Hallucination—Temozolomide—brain cancer	0.000397	0.00363	CcSEcCtD
Amitriptyline—Hypoaesthesia—Temozolomide—brain cancer	0.000397	0.00363	CcSEcCtD
Amitriptyline—Sweating increased—Etoposide—brain cancer	0.000389	0.00355	CcSEcCtD
Amitriptyline—Feeling abnormal—Procarbazine—brain cancer	0.000387	0.00353	CcSEcCtD
Amitriptyline—Convulsion—Hydroxyurea—brain cancer	0.000386	0.00352	CcSEcCtD
Amitriptyline—KCNQ3—brain—brain cancer	0.000382	0.00244	CbGeAlD
Amitriptyline—CHRM4—head—brain cancer	0.000381	0.00244	CbGeAlD
Amitriptyline—Pancytopenia—Etoposide—brain cancer	0.000379	0.00346	CcSEcCtD
Amitriptyline—Discomfort—Hydroxyurea—brain cancer	0.000374	0.00342	CcSEcCtD
Amitriptyline—Urticaria—Procarbazine—brain cancer	0.000373	0.00341	CcSEcCtD
Amitriptyline—Tinnitus—Temozolomide—brain cancer	0.000372	0.0034	CcSEcCtD
Amitriptyline—HTR1B—brainstem—brain cancer	0.000372	0.00238	CbGeAlD
Amitriptyline—Body temperature increased—Procarbazine—brain cancer	0.000371	0.00339	CcSEcCtD
Amitriptyline—Arrhythmia—Carmustine—brain cancer	0.000369	0.00337	CcSEcCtD
Amitriptyline—KCNA1—central nervous system—brain cancer	0.000367	0.00235	CbGeAlD
Amitriptyline—Alopecia—Carmustine—brain cancer	0.000365	0.00334	CcSEcCtD
Amitriptyline—KCND3—central nervous system—brain cancer	0.000365	0.00233	CbGeAlD
Amitriptyline—Oedema—Hydroxyurea—brain cancer	0.000363	0.00332	CcSEcCtD
Amitriptyline—OPRM1—telencephalon—brain cancer	0.000361	0.00231	CbGeAlD
Amitriptyline—HTR1D—brainstem—brain cancer	0.00036	0.0023	CbGeAlD
Amitriptyline—KCNA1—cerebellum—brain cancer	0.000359	0.00229	CbGeAlD
Amitriptyline—KCND3—cerebellum—brain cancer	0.000357	0.00228	CbGeAlD
Amitriptyline—HTR2C—brainstem—brain cancer	0.000357	0.00228	CbGeAlD
Amitriptyline—Thrombocytopenia—Hydroxyurea—brain cancer	0.000356	0.00325	CcSEcCtD
Amitriptyline—HTR2A—endothelium—brain cancer	0.000355	0.00227	CbGeAlD
Amitriptyline—DRD3—head—brain cancer	0.000354	0.00227	CbGeAlD
Amitriptyline—Alopecia—Temozolomide—brain cancer	0.000353	0.00322	CcSEcCtD
Amitriptyline—KCNQ2—brain—brain cancer	0.000351	0.00225	CbGeAlD
Amitriptyline—Acute coronary syndrome—Etoposide—brain cancer	0.000351	0.00321	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Etoposide—brain cancer	0.000349	0.00319	CcSEcCtD
Amitriptyline—Myocardial infarction—Etoposide—brain cancer	0.000349	0.00319	CcSEcCtD
Amitriptyline—CHRM4—central nervous system—brain cancer	0.000348	0.00222	CbGeAlD
Amitriptyline—Jaundice—Etoposide—brain cancer	0.000347	0.00317	CcSEcCtD
Amitriptyline—Stomatitis—Etoposide—brain cancer	0.000347	0.00317	CcSEcCtD
Amitriptyline—Anorexia—Hydroxyurea—brain cancer	0.000346	0.00316	CcSEcCtD
Amitriptyline—HTR6—head—brain cancer	0.000341	0.00218	CbGeAlD
Amitriptyline—Dysgeusia—Temozolomide—brain cancer	0.000341	0.00311	CcSEcCtD
Amitriptyline—Vision blurred—Carmustine—brain cancer	0.000339	0.0031	CcSEcCtD
Amitriptyline—SLC6A4—brainstem—brain cancer	0.000338	0.00216	CbGeAlD
Amitriptyline—Tremor—Carmustine—brain cancer	0.000337	0.00308	CcSEcCtD
Amitriptyline—Asthenia—Procarbazine—brain cancer	0.000337	0.00308	CcSEcCtD
Amitriptyline—KCND2—brain—brain cancer	0.000333	0.00213	CbGeAlD
Amitriptyline—Agranulocytosis—Etoposide—brain cancer	0.000332	0.00303	CcSEcCtD
Amitriptyline—Pruritus—Procarbazine—brain cancer	0.000332	0.00303	CcSEcCtD
Amitriptyline—Agitation—Carmustine—brain cancer	0.000331	0.00302	CcSEcCtD
Amitriptyline—HTR1B—telencephalon—brain cancer	0.00033	0.00211	CbGeAlD
Amitriptyline—OPRD1—head—brain cancer	0.000329	0.00211	CbGeAlD
Amitriptyline—CHRM2—telencephalon—brain cancer	0.000328	0.0021	CbGeAlD
Amitriptyline—Vision blurred—Temozolomide—brain cancer	0.000328	0.00299	CcSEcCtD
Amitriptyline—HTR2A—blood vessel—brain cancer	0.000327	0.00209	CbGeAlD
Amitriptyline—Tremor—Temozolomide—brain cancer	0.000326	0.00298	CcSEcCtD
Amitriptyline—DRD3—central nervous system—brain cancer	0.000323	0.00207	CbGeAlD
Amitriptyline—Somnolence—Hydroxyurea—brain cancer	0.000323	0.00295	CcSEcCtD
Amitriptyline—Ill-defined disorder—Temozolomide—brain cancer	0.000323	0.00295	CcSEcCtD
Amitriptyline—Leukopenia—Carmustine—brain cancer	0.000322	0.00294	CcSEcCtD
Amitriptyline—Diarrhoea—Procarbazine—brain cancer	0.000321	0.00293	CcSEcCtD
Amitriptyline—Dyspepsia—Hydroxyurea—brain cancer	0.00032	0.00292	CcSEcCtD
Amitriptyline—HTR1D—telencephalon—brain cancer	0.00032	0.00204	CbGeAlD
Amitriptyline—Agitation—Temozolomide—brain cancer	0.00032	0.00292	CcSEcCtD
Amitriptyline—Hypoaesthesia—Etoposide—brain cancer	0.000318	0.0029	CcSEcCtD
Amitriptyline—HTR2C—telencephalon—brain cancer	0.000317	0.00202	CbGeAlD
Amitriptyline—HRH2—endocrine gland—brain cancer	0.000316	0.00202	CbGeAlD
Amitriptyline—OPRK1—head—brain cancer	0.000316	0.00202	CbGeAlD
Amitriptyline—Decreased appetite—Hydroxyurea—brain cancer	0.000316	0.00288	CcSEcCtD
Amitriptyline—Malaise—Temozolomide—brain cancer	0.000314	0.00286	CcSEcCtD
Amitriptyline—Fatigue—Hydroxyurea—brain cancer	0.000313	0.00286	CcSEcCtD
Amitriptyline—HTR2A—hindbrain—brain cancer	0.000312	0.002	CbGeAlD
Amitriptyline—HRH2—head—brain cancer	0.000312	0.00199	CbGeAlD
Amitriptyline—Convulsion—Carmustine—brain cancer	0.000312	0.00285	CcSEcCtD
Amitriptyline—HTR6—central nervous system—brain cancer	0.000311	0.00199	CbGeAlD
Amitriptyline—Leukopenia—Temozolomide—brain cancer	0.000311	0.00284	CcSEcCtD
Amitriptyline—Hypertension—Carmustine—brain cancer	0.000311	0.00284	CcSEcCtD
Amitriptyline—Constipation—Hydroxyurea—brain cancer	0.000311	0.00284	CcSEcCtD
Amitriptyline—Dizziness—Procarbazine—brain cancer	0.00031	0.00283	CcSEcCtD
Amitriptyline—Palpitations—Temozolomide—brain cancer	0.000307	0.00281	CcSEcCtD
Amitriptyline—Anxiety—Carmustine—brain cancer	0.000305	0.00279	CcSEcCtD
Amitriptyline—Convulsion—Temozolomide—brain cancer	0.000301	0.00275	CcSEcCtD
Amitriptyline—OPRD1—central nervous system—brain cancer	0.000301	0.00192	CbGeAlD
Amitriptyline—Hypertension—Temozolomide—brain cancer	0.0003	0.00274	CcSEcCtD
Amitriptyline—HTR1A—brainstem—brain cancer	0.0003	0.00192	CbGeAlD
Amitriptyline—SLC6A4—telencephalon—brain cancer	0.0003	0.00192	CbGeAlD
Amitriptyline—Feeling abnormal—Hydroxyurea—brain cancer	0.000299	0.00273	CcSEcCtD
Amitriptyline—CHRM1—telencephalon—brain cancer	0.000299	0.00191	CbGeAlD
Amitriptyline—Vomiting—Procarbazine—brain cancer	0.000298	0.00273	CcSEcCtD
Amitriptyline—SIGMAR1—telencephalon—brain cancer	0.000298	0.00191	CbGeAlD
Amitriptyline—CHRM5—head—brain cancer	0.000298	0.0019	CbGeAlD
Amitriptyline—SLC6A2—brainstem—brain cancer	0.000298	0.0019	CbGeAlD
Amitriptyline—Confusional state—Carmustine—brain cancer	0.000296	0.0027	CcSEcCtD
Amitriptyline—Rash—Procarbazine—brain cancer	0.000296	0.0027	CcSEcCtD
Amitriptyline—Dermatitis—Procarbazine—brain cancer	0.000296	0.0027	CcSEcCtD
Amitriptyline—Anxiety—Temozolomide—brain cancer	0.000295	0.00269	CcSEcCtD
Amitriptyline—Headache—Procarbazine—brain cancer	0.000294	0.00269	CcSEcCtD
Amitriptyline—Oedema—Carmustine—brain cancer	0.000294	0.00268	CcSEcCtD
Amitriptyline—Discomfort—Temozolomide—brain cancer	0.000293	0.00267	CcSEcCtD
Amitriptyline—KCNA1—brain—brain cancer	0.000291	0.00186	CbGeAlD
Amitriptyline—KCND3—brain—brain cancer	0.00029	0.00185	CbGeAlD
Amitriptyline—Dry mouth—Temozolomide—brain cancer	0.00029	0.00264	CcSEcCtD
Amitriptyline—OPRK1—central nervous system—brain cancer	0.000288	0.00184	CbGeAlD
Amitriptyline—Thrombocytopenia—Carmustine—brain cancer	0.000288	0.00263	CcSEcCtD
Amitriptyline—Body temperature increased—Hydroxyurea—brain cancer	0.000287	0.00262	CcSEcCtD
Amitriptyline—HTR7—brainstem—brain cancer	0.000287	0.00183	CbGeAlD
Amitriptyline—Tachycardia—Carmustine—brain cancer	0.000287	0.00262	CcSEcCtD
Amitriptyline—Confusional state—Temozolomide—brain cancer	0.000286	0.00261	CcSEcCtD
Amitriptyline—HRH2—central nervous system—brain cancer	0.000285	0.00182	CbGeAlD
Amitriptyline—CYP2D6—hindbrain—brain cancer	0.000284	0.00182	CbGeAlD
Amitriptyline—Oedema—Temozolomide—brain cancer	0.000284	0.00259	CcSEcCtD
Amitriptyline—Alopecia—Etoposide—brain cancer	0.000282	0.00258	CcSEcCtD
Amitriptyline—OPRK1—cerebellum—brain cancer	0.000282	0.0018	CbGeAlD
Amitriptyline—Anorexia—Carmustine—brain cancer	0.00028	0.00256	CcSEcCtD
Amitriptyline—Nausea—Procarbazine—brain cancer	0.000279	0.00255	CcSEcCtD
Amitriptyline—Thrombocytopenia—Temozolomide—brain cancer	0.000278	0.00254	CcSEcCtD
Amitriptyline—ADRA1A—brainstem—brain cancer	0.000277	0.00177	CbGeAlD
Amitriptyline—CHRM4—brain—brain cancer	0.000276	0.00177	CbGeAlD
Amitriptyline—Hypotension—Carmustine—brain cancer	0.000274	0.00251	CcSEcCtD
Amitriptyline—Hyperhidrosis—Temozolomide—brain cancer	0.000274	0.00251	CcSEcCtD
Amitriptyline—Nortriptyline—CYP2C9—brain cancer	0.000274	0.183	CrCbGaD
Amitriptyline—Dysgeusia—Etoposide—brain cancer	0.000272	0.00249	CcSEcCtD
Amitriptyline—ADRA1B—head—brain cancer	0.000272	0.00174	CbGeAlD
Amitriptyline—CHRM5—central nervous system—brain cancer	0.000272	0.00174	CbGeAlD
Amitriptyline—DRD2—brainstem—brain cancer	0.000271	0.00173	CbGeAlD
Amitriptyline—Anorexia—Temozolomide—brain cancer	0.000271	0.00247	CcSEcCtD
Amitriptyline—ADRA1D—endocrine gland—brain cancer	0.00027	0.00172	CbGeAlD
Amitriptyline—CHRM3—telencephalon—brain cancer	0.000267	0.00171	CbGeAlD
Amitriptyline—HTR1A—telencephalon—brain cancer	0.000266	0.0017	CbGeAlD
Amitriptyline—ADRA1D—head—brain cancer	0.000266	0.0017	CbGeAlD
Amitriptyline—Insomnia—Carmustine—brain cancer	0.000266	0.00243	CcSEcCtD
Amitriptyline—SLC6A2—telencephalon—brain cancer	0.000264	0.00169	CbGeAlD
Amitriptyline—Paraesthesia—Carmustine—brain cancer	0.000264	0.00241	CcSEcCtD
Amitriptyline—Somnolence—Carmustine—brain cancer	0.000261	0.00238	CcSEcCtD
Amitriptyline—Asthenia—Hydroxyurea—brain cancer	0.000261	0.00238	CcSEcCtD
Amitriptyline—OPRM1—midbrain—brain cancer	0.000259	0.00166	CbGeAlD
Amitriptyline—Ill-defined disorder—Etoposide—brain cancer	0.000258	0.00236	CcSEcCtD
Amitriptyline—Trimipramine—CYP2C9—brain cancer	0.000258	0.172	CrCbGaD
Amitriptyline—DRD3—brain—brain cancer	0.000257	0.00164	CbGeAlD
Amitriptyline—Insomnia—Temozolomide—brain cancer	0.000257	0.00234	CcSEcCtD
Amitriptyline—Decreased appetite—Carmustine—brain cancer	0.000255	0.00233	CcSEcCtD
Amitriptyline—Paraesthesia—Temozolomide—brain cancer	0.000255	0.00233	CcSEcCtD
Amitriptyline—HTR7—telencephalon—brain cancer	0.000255	0.00163	CbGeAlD
Amitriptyline—Diphenhydramine—CYP2C9—brain cancer	0.000254	0.169	CrCbGaD
Amitriptyline—OPRM1—spinal cord—brain cancer	0.000253	0.00162	CbGeAlD
Amitriptyline—Somnolence—Temozolomide—brain cancer	0.000252	0.0023	CcSEcCtD
Amitriptyline—Constipation—Carmustine—brain cancer	0.000251	0.00229	CcSEcCtD
Amitriptyline—Malaise—Etoposide—brain cancer	0.000251	0.00229	CcSEcCtD
Amitriptyline—Dyspepsia—Temozolomide—brain cancer	0.00025	0.00228	CcSEcCtD
Amitriptyline—Leukopenia—Etoposide—brain cancer	0.000249	0.00227	CcSEcCtD
Amitriptyline—HTR2C—medulla oblongata—brain cancer	0.000249	0.00159	CbGeAlD
Amitriptyline—Promethazine—CYP2C9—brain cancer	0.000249	0.166	CrCbGaD
Amitriptyline—Diarrhoea—Hydroxyurea—brain cancer	0.000249	0.00227	CcSEcCtD
Amitriptyline—ADRA1B—central nervous system—brain cancer	0.000248	0.00159	CbGeAlD
Amitriptyline—HTR6—brain—brain cancer	0.000247	0.00158	CbGeAlD
Amitriptyline—ORM1—spinal cord—brain cancer	0.000247	0.00158	CbGeAlD
Amitriptyline—Decreased appetite—Temozolomide—brain cancer	0.000247	0.00225	CcSEcCtD
Amitriptyline—Doxepin—CYP2C9—brain cancer	0.000246	0.164	CrCbGaD
Amitriptyline—ADRA1A—telencephalon—brain cancer	0.000246	0.00157	CbGeAlD
Amitriptyline—Fatigue—Temozolomide—brain cancer	0.000245	0.00223	CcSEcCtD
Amitriptyline—Loss of consciousness—Etoposide—brain cancer	0.000245	0.00223	CcSEcCtD
Amitriptyline—ADRA1D—central nervous system—brain cancer	0.000243	0.00155	CbGeAlD
Amitriptyline—Constipation—Temozolomide—brain cancer	0.000243	0.00222	CcSEcCtD
Amitriptyline—SIGMAR1—pituitary gland—brain cancer	0.000243	0.00155	CbGeAlD
Amitriptyline—Feeling abnormal—Carmustine—brain cancer	0.000242	0.00221	CcSEcCtD
Amitriptyline—Convulsion—Etoposide—brain cancer	0.000241	0.0022	CcSEcCtD
Amitriptyline—DRD2—telencephalon—brain cancer	0.000241	0.00154	CbGeAlD
Amitriptyline—Hypertension—Etoposide—brain cancer	0.00024	0.00219	CcSEcCtD
Amitriptyline—Dizziness—Hydroxyurea—brain cancer	0.00024	0.00219	CcSEcCtD
Amitriptyline—OPRD1—brain—brain cancer	0.000239	0.00153	CbGeAlD
Amitriptyline—HTR1B—midbrain—brain cancer	0.000237	0.00152	CbGeAlD
Amitriptyline—SIGMAR1—medulla oblongata—brain cancer	0.000234	0.0015	CbGeAlD
Amitriptyline—Discomfort—Etoposide—brain cancer	0.000234	0.00214	CcSEcCtD
Amitriptyline—Feeling abnormal—Temozolomide—brain cancer	0.000234	0.00214	CcSEcCtD
Amitriptyline—Body temperature increased—Carmustine—brain cancer	0.000232	0.00212	CcSEcCtD
Amitriptyline—HTR1B—spinal cord—brain cancer	0.000231	0.00148	CbGeAlD
Amitriptyline—Vomiting—Hydroxyurea—brain cancer	0.000231	0.00211	CcSEcCtD
Amitriptyline—HTR1D—midbrain—brain cancer	0.00023	0.00147	CbGeAlD
Amitriptyline—Rash—Hydroxyurea—brain cancer	0.000229	0.00209	CcSEcCtD
Amitriptyline—Confusional state—Etoposide—brain cancer	0.000229	0.00209	CcSEcCtD
Amitriptyline—OPRK1—brain—brain cancer	0.000229	0.00146	CbGeAlD
Amitriptyline—Dermatitis—Hydroxyurea—brain cancer	0.000229	0.00209	CcSEcCtD
Amitriptyline—Headache—Hydroxyurea—brain cancer	0.000228	0.00208	CcSEcCtD
Amitriptyline—OPRM1—endocrine gland—brain cancer	0.000228	0.00145	CbGeAlD
Amitriptyline—HTR2C—midbrain—brain cancer	0.000227	0.00145	CbGeAlD
Amitriptyline—HRH2—brain—brain cancer	0.000226	0.00144	CbGeAlD
Amitriptyline—Urticaria—Temozolomide—brain cancer	0.000225	0.00206	CcSEcCtD
Amitriptyline—OPRM1—head—brain cancer	0.000225	0.00144	CbGeAlD
Amitriptyline—Body temperature increased—Temozolomide—brain cancer	0.000224	0.00205	CcSEcCtD
Amitriptyline—Thrombocytopenia—Etoposide—brain cancer	0.000222	0.00203	CcSEcCtD
Amitriptyline—ORM1—endocrine gland—brain cancer	0.000222	0.00142	CbGeAlD
Amitriptyline—HTR2C—spinal cord—brain cancer	0.000222	0.00142	CbGeAlD
Amitriptyline—Tachycardia—Etoposide—brain cancer	0.000222	0.00202	CcSEcCtD
Amitriptyline—SLC6A2—gonad—brain cancer	0.00022	0.00141	CbGeAlD
Amitriptyline—Hyperhidrosis—Etoposide—brain cancer	0.00022	0.002	CcSEcCtD
Amitriptyline—Promazine—CYP2C9—brain cancer	0.000219	0.146	CrCbGaD
Amitriptyline—Anorexia—Etoposide—brain cancer	0.000216	0.00198	CcSEcCtD
Amitriptyline—CHRM5—brain—brain cancer	0.000216	0.00138	CbGeAlD
Amitriptyline—Nausea—Hydroxyurea—brain cancer	0.000216	0.00197	CcSEcCtD
Amitriptyline—SLC6A4—midbrain—brain cancer	0.000215	0.00138	CbGeAlD
Amitriptyline—ABCB1—blood vessel—brain cancer	0.000214	0.00137	CbGeAlD
Amitriptyline—SIGMAR1—midbrain—brain cancer	0.000214	0.00137	CbGeAlD
Amitriptyline—HTR7—gonad—brain cancer	0.000212	0.00136	CbGeAlD
Amitriptyline—Hypotension—Etoposide—brain cancer	0.000212	0.00194	CcSEcCtD
Amitriptyline—Asthenia—Carmustine—brain cancer	0.000211	0.00192	CcSEcCtD
Amitriptyline—SLC6A4—spinal cord—brain cancer	0.00021	0.00134	CbGeAlD
Amitriptyline—SIGMAR1—spinal cord—brain cancer	0.000209	0.00133	CbGeAlD
Amitriptyline—HTR1B—endocrine gland—brain cancer	0.000208	0.00133	CbGeAlD
Amitriptyline—SLC6A2—medulla oblongata—brain cancer	0.000208	0.00133	CbGeAlD
Amitriptyline—CHRM2—endocrine gland—brain cancer	0.000207	0.00132	CbGeAlD
Amitriptyline—HTR1B—head—brain cancer	0.000206	0.00131	CbGeAlD
Amitriptyline—OPRM1—central nervous system—brain cancer	0.000205	0.00131	CbGeAlD
Amitriptyline—CHRM2—head—brain cancer	0.000204	0.00131	CbGeAlD
Amitriptyline—Paraesthesia—Etoposide—brain cancer	0.000204	0.00186	CcSEcCtD
Amitriptyline—Asthenia—Temozolomide—brain cancer	0.000204	0.00186	CcSEcCtD
Amitriptyline—Somnolence—Etoposide—brain cancer	0.000202	0.00184	CcSEcCtD
Amitriptyline—Diarrhoea—Carmustine—brain cancer	0.000201	0.00183	CcSEcCtD
Amitriptyline—Pruritus—Temozolomide—brain cancer	0.000201	0.00183	CcSEcCtD
Amitriptyline—ORM1—central nervous system—brain cancer	0.0002	0.00128	CbGeAlD
Amitriptyline—HTR7—medulla oblongata—brain cancer	0.0002	0.00128	CbGeAlD
Amitriptyline—HTR1D—head—brain cancer	0.000199	0.00127	CbGeAlD
Amitriptyline—Decreased appetite—Etoposide—brain cancer	0.000197	0.0018	CcSEcCtD
Amitriptyline—ADRA1B—brain—brain cancer	0.000197	0.00126	CbGeAlD
Amitriptyline—HTR2C—head—brain cancer	0.000197	0.00126	CbGeAlD
Amitriptyline—DRD2—pituitary gland—brain cancer	0.000196	0.00125	CbGeAlD
Amitriptyline—Fatigue—Etoposide—brain cancer	0.000196	0.00179	CcSEcCtD
Amitriptyline—Dizziness—Carmustine—brain cancer	0.000194	0.00177	CcSEcCtD
Amitriptyline—Constipation—Etoposide—brain cancer	0.000194	0.00177	CcSEcCtD
Amitriptyline—Diarrhoea—Temozolomide—brain cancer	0.000194	0.00177	CcSEcCtD
Amitriptyline—ADRA1D—brain—brain cancer	0.000193	0.00123	CbGeAlD
Amitriptyline—HTR1A—midbrain—brain cancer	0.000191	0.00122	CbGeAlD
Amitriptyline—HRH1—telencephalon—brain cancer	0.00019	0.00122	CbGeAlD
Amitriptyline—SLC6A4—endocrine gland—brain cancer	0.000189	0.00121	CbGeAlD
Amitriptyline—CHRM1—endocrine gland—brain cancer	0.000189	0.00121	CbGeAlD
Amitriptyline—Dizziness—Temozolomide—brain cancer	0.000188	0.00171	CcSEcCtD
Amitriptyline—HTR1B—central nervous system—brain cancer	0.000188	0.0012	CbGeAlD
Amitriptyline—Feeling abnormal—Etoposide—brain cancer	0.000187	0.00171	CcSEcCtD
Amitriptyline—SLC6A4—head—brain cancer	0.000187	0.00119	CbGeAlD
Amitriptyline—ADRA2A—telencephalon—brain cancer	0.000187	0.00119	CbGeAlD
Amitriptyline—Vomiting—Carmustine—brain cancer	0.000187	0.00171	CcSEcCtD
Amitriptyline—HTR1A—spinal cord—brain cancer	0.000187	0.00119	CbGeAlD
Amitriptyline—CHRM2—central nervous system—brain cancer	0.000187	0.00119	CbGeAlD
Amitriptyline—CHRM1—head—brain cancer	0.000186	0.00119	CbGeAlD
Amitriptyline—Rash—Carmustine—brain cancer	0.000185	0.00169	CcSEcCtD
Amitriptyline—Dermatitis—Carmustine—brain cancer	0.000185	0.00169	CcSEcCtD
Amitriptyline—Headache—Carmustine—brain cancer	0.000184	0.00168	CcSEcCtD
Amitriptyline—HTR7—midbrain—brain cancer	0.000183	0.00117	CbGeAlD
Amitriptyline—CYP2E1—telencephalon—brain cancer	0.000183	0.00117	CbGeAlD
Amitriptyline—HTR1D—central nervous system—brain cancer	0.000182	0.00116	CbGeAlD
Amitriptyline—Vomiting—Temozolomide—brain cancer	0.00018	0.00165	CcSEcCtD
Amitriptyline—Urticaria—Etoposide—brain cancer	0.00018	0.00165	CcSEcCtD
Amitriptyline—HTR2C—central nervous system—brain cancer	0.00018	0.00115	CbGeAlD
Amitriptyline—Body temperature increased—Etoposide—brain cancer	0.00018	0.00164	CcSEcCtD
Amitriptyline—Rash—Temozolomide—brain cancer	0.000179	0.00163	CcSEcCtD
Amitriptyline—HTR2A—brainstem—brain cancer	0.000179	0.00114	CbGeAlD
Amitriptyline—Dermatitis—Temozolomide—brain cancer	0.000179	0.00163	CcSEcCtD
Amitriptyline—HTR7—spinal cord—brain cancer	0.000178	0.00114	CbGeAlD
Amitriptyline—Headache—Temozolomide—brain cancer	0.000178	0.00162	CcSEcCtD
Amitriptyline—CYP2C8—pituitary gland—brain cancer	0.000177	0.00113	CbGeAlD
Amitriptyline—Nausea—Carmustine—brain cancer	0.000174	0.00159	CcSEcCtD
Amitriptyline—DRD2—midbrain—brain cancer	0.000173	0.00111	CbGeAlD
Amitriptyline—SLC6A4—central nervous system—brain cancer	0.000171	0.00109	CbGeAlD
Amitriptyline—CHRM1—central nervous system—brain cancer	0.00017	0.00109	CbGeAlD
Amitriptyline—CHRM3—endocrine gland—brain cancer	0.000169	0.00108	CbGeAlD
Amitriptyline—Nausea—Temozolomide—brain cancer	0.000169	0.00154	CcSEcCtD
Amitriptyline—HTR1A—endocrine gland—brain cancer	0.000168	0.00107	CbGeAlD
Amitriptyline—SLC6A2—endocrine gland—brain cancer	0.000167	0.00107	CbGeAlD
Amitriptyline—CHRM3—head—brain cancer	0.000167	0.00106	CbGeAlD
Amitriptyline—HTR1A—head—brain cancer	0.000166	0.00106	CbGeAlD
Amitriptyline—SIGMAR1—cerebellum—brain cancer	0.000166	0.00106	CbGeAlD
Amitriptyline—SLC6A2—head—brain cancer	0.000164	0.00105	CbGeAlD
Amitriptyline—CYP2D6—brainstem—brain cancer	0.000163	0.00104	CbGeAlD
Amitriptyline—Asthenia—Etoposide—brain cancer	0.000163	0.00149	CcSEcCtD
Amitriptyline—OPRM1—brain—brain cancer	0.000163	0.00104	CbGeAlD
Amitriptyline—CYP2B6—gonad—brain cancer	0.000162	0.00104	CbGeAlD
Amitriptyline—Pruritus—Etoposide—brain cancer	0.000161	0.00147	CcSEcCtD
Amitriptyline—HTR7—endocrine gland—brain cancer	0.000161	0.00103	CbGeAlD
Amitriptyline—HTR2A—telencephalon—brain cancer	0.000159	0.00102	CbGeAlD
Amitriptyline—HTR7—head—brain cancer	0.000159	0.00101	CbGeAlD
Amitriptyline—CYP2C19—endocrine gland—brain cancer	0.000157	0.001	CbGeAlD
Amitriptyline—ADRA2A—gonad—brain cancer	0.000156	0.000996	CbGeAlD
Amitriptyline—Diarrhoea—Etoposide—brain cancer	0.000155	0.00142	CcSEcCtD
Amitriptyline—ADRA1A—endocrine gland—brain cancer	0.000155	0.00099	CbGeAlD
Amitriptyline—ADRA1A—head—brain cancer	0.000153	0.000978	CbGeAlD
Amitriptyline—ADRA2A—pituitary gland—brain cancer	0.000152	0.000972	CbGeAlD
Amitriptyline—CHRM3—central nervous system—brain cancer	0.000152	0.000972	CbGeAlD
Amitriptyline—DRD2—endocrine gland—brain cancer	0.000152	0.000971	CbGeAlD
Amitriptyline—HTR1A—central nervous system—brain cancer	0.000151	0.000968	CbGeAlD
Amitriptyline—Dizziness—Etoposide—brain cancer	0.00015	0.00137	CcSEcCtD
Amitriptyline—SLC6A2—central nervous system—brain cancer	0.00015	0.00096	CbGeAlD
Amitriptyline—DRD2—head—brain cancer	0.00015	0.000958	CbGeAlD
Amitriptyline—HTR1B—brain—brain cancer	0.000149	0.000952	CbGeAlD
Amitriptyline—CHRM2—brain—brain cancer	0.000148	0.000947	CbGeAlD
Amitriptyline—HTR1A—cerebellum—brain cancer	0.000148	0.000946	CbGeAlD
Amitriptyline—ADRA2A—medulla oblongata—brain cancer	0.000147	0.000938	CbGeAlD
Amitriptyline—HTR7—central nervous system—brain cancer	0.000145	0.000925	CbGeAlD
Amitriptyline—CYP2D6—telencephalon—brain cancer	0.000145	0.000925	CbGeAlD
Amitriptyline—Vomiting—Etoposide—brain cancer	0.000144	0.00132	CcSEcCtD
Amitriptyline—HTR1D—brain—brain cancer	0.000144	0.000922	CbGeAlD
Amitriptyline—CYP2E1—medulla oblongata—brain cancer	0.000144	0.000918	CbGeAlD
Amitriptyline—Rash—Etoposide—brain cancer	0.000143	0.00131	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—brain cancer	0.000143	0.00131	CcSEcCtD
Amitriptyline—HTR2C—brain—brain cancer	0.000143	0.000913	CbGeAlD
Amitriptyline—Headache—Etoposide—brain cancer	0.000142	0.0013	CcSEcCtD
Amitriptyline—HTR7—cerebellum—brain cancer	0.000141	0.000904	CbGeAlD
Amitriptyline—ADRA1A—central nervous system—brain cancer	0.00014	0.000892	CbGeAlD
Amitriptyline—ALB—brain—brain cancer	0.000139	0.000891	CbGeAlD
Amitriptyline—CYP2C8—endocrine gland—brain cancer	0.000137	0.000875	CbGeAlD
Amitriptyline—DRD2—central nervous system—brain cancer	0.000137	0.000875	CbGeAlD
Amitriptyline—ADRA1A—cerebellum—brain cancer	0.000136	0.000872	CbGeAlD
Amitriptyline—SLC6A4—brain—brain cancer	0.000135	0.000866	CbGeAlD
Amitriptyline—Nausea—Etoposide—brain cancer	0.000135	0.00123	CcSEcCtD
Amitriptyline—CHRM1—brain—brain cancer	0.000135	0.000862	CbGeAlD
Amitriptyline—SIGMAR1—brain—brain cancer	0.000134	0.00086	CbGeAlD
Amitriptyline—ADRA2A—midbrain—brain cancer	0.000134	0.000857	CbGeAlD
Amitriptyline—DRD2—cerebellum—brain cancer	0.000134	0.000855	CbGeAlD
Amitriptyline—HTR2A—gonad—brain cancer	0.000133	0.000847	CbGeAlD
Amitriptyline—ADRA2A—spinal cord—brain cancer	0.000131	0.000836	CbGeAlD
Amitriptyline—HTR2A—pituitary gland—brain cancer	0.000129	0.000826	CbGeAlD
Amitriptyline—CYP1A2—endocrine gland—brain cancer	0.000128	0.000819	CbGeAlD
Amitriptyline—CYP2E1—spinal cord—brain cancer	0.000128	0.000818	CbGeAlD
Amitriptyline—HTR2A—medulla oblongata—brain cancer	0.000125	0.000798	CbGeAlD
Amitriptyline—CYP3A5—endocrine gland—brain cancer	0.000124	0.00079	CbGeAlD
Amitriptyline—CYP2B6—endocrine gland—brain cancer	0.000123	0.000785	CbGeAlD
Amitriptyline—CYP2C9—endocrine gland—brain cancer	0.000122	0.000777	CbGeAlD
Amitriptyline—CYP2B6—head—brain cancer	0.000121	0.000775	CbGeAlD
Amitriptyline—CHRM3—brain—brain cancer	0.000121	0.000772	CbGeAlD
Amitriptyline—HTR1A—brain—brain cancer	0.00012	0.000769	CbGeAlD
Amitriptyline—HRH1—endocrine gland—brain cancer	0.00012	0.000767	CbGeAlD
Amitriptyline—SLC6A2—brain—brain cancer	0.000119	0.000762	CbGeAlD
Amitriptyline—HRH1—head—brain cancer	0.000118	0.000757	CbGeAlD
Amitriptyline—ADRA2A—endocrine gland—brain cancer	0.000118	0.000753	CbGeAlD
Amitriptyline—ADRA2A—head—brain cancer	0.000116	0.000743	CbGeAlD
Amitriptyline—CYP2E1—endocrine gland—brain cancer	0.000115	0.000737	CbGeAlD
Amitriptyline—HTR7—brain—brain cancer	0.000115	0.000735	CbGeAlD
Amitriptyline—HTR2A—midbrain—brain cancer	0.000114	0.000729	CbGeAlD
Amitriptyline—CYP2E1—head—brain cancer	0.000114	0.000727	CbGeAlD
Amitriptyline—HTR2A—spinal cord—brain cancer	0.000111	0.000711	CbGeAlD
Amitriptyline—ADRA1A—brain—brain cancer	0.000111	0.000708	CbGeAlD
Amitriptyline—CYP2B6—central nervous system—brain cancer	0.000111	0.000707	CbGeAlD
Amitriptyline—DRD2—brain—brain cancer	0.000109	0.000694	CbGeAlD
Amitriptyline—HRH1—central nervous system—brain cancer	0.000108	0.000691	CbGeAlD
Amitriptyline—ADRA2A—central nervous system—brain cancer	0.000106	0.000679	CbGeAlD
Amitriptyline—ABCB1—telencephalon—brain cancer	0.000104	0.000665	CbGeAlD
Amitriptyline—CYP2E1—central nervous system—brain cancer	0.000104	0.000664	CbGeAlD
Amitriptyline—ADRA2A—cerebellum—brain cancer	0.000104	0.000663	CbGeAlD
Amitriptyline—CYP2E1—cerebellum—brain cancer	0.000101	0.000649	CbGeAlD
Amitriptyline—HTR2A—endocrine gland—brain cancer	0.0001	0.00064	CbGeAlD
Amitriptyline—HTR2A—head—brain cancer	9.89e-05	0.000632	CbGeAlD
Amitriptyline—CYP2C8—brain—brain cancer	9.79e-05	0.000626	CbGeAlD
Amitriptyline—CYP3A4—endocrine gland—brain cancer	9.27e-05	0.000593	CbGeAlD
Amitriptyline—CYP2D6—endocrine gland—brain cancer	9.12e-05	0.000583	CbGeAlD
Amitriptyline—HTR2A—central nervous system—brain cancer	9.02e-05	0.000577	CbGeAlD
Amitriptyline—CYP2D6—head—brain cancer	9.01e-05	0.000576	CbGeAlD
Amitriptyline—HTR2A—cerebellum—brain cancer	8.82e-05	0.000564	CbGeAlD
Amitriptyline—CYP2B6—brain—brain cancer	8.78e-05	0.000562	CbGeAlD
Amitriptyline—ABCB1—gonad—brain cancer	8.68e-05	0.000555	CbGeAlD
Amitriptyline—HRH1—brain—brain cancer	8.58e-05	0.000548	CbGeAlD
Amitriptyline—ABCB1—pituitary gland—brain cancer	8.47e-05	0.000542	CbGeAlD
Amitriptyline—ADRA2A—brain—brain cancer	8.43e-05	0.000539	CbGeAlD
Amitriptyline—CYP3A4—central nervous system—brain cancer	8.35e-05	0.000534	CbGeAlD
Amitriptyline—CYP2E1—brain—brain cancer	8.24e-05	0.000527	CbGeAlD
Amitriptyline—CYP2D6—central nervous system—brain cancer	8.22e-05	0.000526	CbGeAlD
Amitriptyline—ABCB1—medulla oblongata—brain cancer	8.17e-05	0.000523	CbGeAlD
Amitriptyline—CYP2D6—cerebellum—brain cancer	8.04e-05	0.000514	CbGeAlD
Amitriptyline—ABCB1—midbrain—brain cancer	7.47e-05	0.000478	CbGeAlD
Amitriptyline—ABCB1—spinal cord—brain cancer	7.29e-05	0.000466	CbGeAlD
Amitriptyline—HTR2A—brain—brain cancer	7.16e-05	0.000458	CbGeAlD
Amitriptyline—ABCB1—endocrine gland—brain cancer	6.56e-05	0.00042	CbGeAlD
Amitriptyline—CYP2D6—brain—brain cancer	6.53e-05	0.000417	CbGeAlD
Amitriptyline—ABCB1—head—brain cancer	6.48e-05	0.000414	CbGeAlD
Amitriptyline—ABCB1—central nervous system—brain cancer	5.91e-05	0.000378	CbGeAlD
Amitriptyline—ABCB1—cerebellum—brain cancer	5.78e-05	0.00037	CbGeAlD
Amitriptyline—ABCB1—brain—brain cancer	4.69e-05	0.0003	CbGeAlD
Amitriptyline—CHRM5—Signaling Pathways—RELA—brain cancer	5.38e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	5.37e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—APC—brain cancer	5.37e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL2—brain cancer	5.36e-06	5.07e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL2—brain cancer	5.36e-06	5.06e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—EGFR—brain cancer	5.35e-06	5.06e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—ERBB2—brain cancer	5.34e-06	5.05e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL2—brain cancer	5.32e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CCND1—brain cancer	5.3e-06	5.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CG—brain cancer	5.3e-06	5.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL2—brain cancer	5.28e-06	4.99e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—TP53—brain cancer	5.27e-06	4.99e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—VEGFA—brain cancer	5.27e-06	4.99e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CTNNB1—brain cancer	5.25e-06	4.97e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CCND1—brain cancer	5.23e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CCND1—brain cancer	5.22e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—STAT3—brain cancer	5.22e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL2—brain cancer	5.21e-06	4.93e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CCND1—brain cancer	5.19e-06	4.9e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CTNNB1—brain cancer	5.18e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CTNNB1—brain cancer	5.17e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—EGFR—brain cancer	5.14e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CTNNB1—brain cancer	5.14e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—EGFR—brain cancer	5.11e-06	4.83e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—RELA—brain cancer	5.1e-06	4.83e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CCND1—brain cancer	5.08e-06	4.8e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—ERBB2—brain cancer	5.07e-06	4.8e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL2—brain cancer	5.06e-06	4.78e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—RELA—brain cancer	5.06e-06	4.78e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—RELA—brain cancer	5.06e-06	4.78e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CTNNB1—brain cancer	5.03e-06	4.76e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—ERBB2—brain cancer	5.02e-06	4.75e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—ERBB2—brain cancer	5.02e-06	4.75e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IRS2—brain cancer	5.02e-06	4.75e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CG—brain cancer	4.97e-06	4.7e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—APC—brain cancer	4.95e-06	4.68e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CG—brain cancer	4.95e-06	4.68e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CCND1—brain cancer	4.93e-06	4.66e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ENO2—brain cancer	4.92e-06	4.65e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—EGFR—brain cancer	4.89e-06	4.63e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CTNNB1—brain cancer	4.88e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CG—brain cancer	4.87e-06	4.61e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—APC—brain cancer	4.87e-06	4.61e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CG—brain cancer	4.87e-06	4.6e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CG—brain cancer	4.86e-06	4.6e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—APC—brain cancer	4.86e-06	4.6e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CG—brain cancer	4.86e-06	4.59e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MYC—brain cancer	4.85e-06	4.59e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—APC—brain cancer	4.85e-06	4.58e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CG—brain cancer	4.85e-06	4.58e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL2—brain cancer	4.84e-06	4.58e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—APC—brain cancer	4.83e-06	4.57e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CG—brain cancer	4.83e-06	4.57e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CG—brain cancer	4.78e-06	4.52e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—APC—brain cancer	4.78e-06	4.52e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—APC—brain cancer	4.77e-06	4.51e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	4.77e-06	4.51e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—EGFR—brain cancer	4.74e-06	4.49e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CCND1—brain cancer	4.72e-06	4.46e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CTNNB1—brain cancer	4.68e-06	4.42e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—TP53—brain cancer	4.66e-06	4.41e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—VEGFA—brain cancer	4.62e-06	4.37e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL2—brain cancer	4.6e-06	4.35e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—STAT3—brain cancer	4.58e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—VEGFA—brain cancer	4.56e-06	4.31e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL2—brain cancer	4.55e-06	4.31e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL2—brain cancer	4.55e-06	4.31e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—VEGFA—brain cancer	4.55e-06	4.3e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—VEGFA—brain cancer	4.52e-06	4.28e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—STAT3—brain cancer	4.51e-06	4.27e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—EGFR—brain cancer	4.51e-06	4.27e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—STAT3—brain cancer	4.51e-06	4.26e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—TP53—brain cancer	4.49e-06	4.24e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CCND1—brain cancer	4.48e-06	4.24e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—STAT3—brain cancer	4.48e-06	4.23e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CCND1—brain cancer	4.44e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CCND1—brain cancer	4.44e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—EGFR—brain cancer	4.44e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CTNNB1—brain cancer	4.44e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	4.43e-06	4.19e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—APC—brain cancer	4.43e-06	4.19e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—EGFR—brain cancer	4.43e-06	4.19e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—VEGFA—brain cancer	4.43e-06	4.19e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—EGFR—brain cancer	4.41e-06	4.17e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—RELA—brain cancer	4.41e-06	4.17e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—EGFR—brain cancer	4.4e-06	4.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	4.4e-06	4.16e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CTNNB1—brain cancer	4.4e-06	4.16e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—RELA—brain cancer	4.38e-06	4.15e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—STAT3—brain cancer	4.38e-06	4.15e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—ERBB2—brain cancer	4.38e-06	4.14e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—EGFR—brain cancer	4.36e-06	4.12e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—ERBB2—brain cancer	4.36e-06	4.12e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—EGFR—brain cancer	4.35e-06	4.11e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—VEGFA—brain cancer	4.3e-06	4.06e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—STAT3—brain cancer	4.26e-06	4.02e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MYC—brain cancer	4.25e-06	4.02e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CG—brain cancer	4.21e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—RELA—brain cancer	4.2e-06	3.97e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MYC—brain cancer	4.19e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MYC—brain cancer	4.19e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CG—brain cancer	4.18e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—ERBB2—brain cancer	4.17e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—EGFR—brain cancer	4.16e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MYC—brain cancer	4.16e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—VEGFA—brain cancer	4.12e-06	3.89e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—EGFR—brain cancer	4.1e-06	3.88e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—EGFR—brain cancer	4.1e-06	3.87e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—STAT3—brain cancer	4.08e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MYC—brain cancer	4.07e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—EGFR—brain cancer	4.07e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—EGFR—brain cancer	4.04e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—EGFR—brain cancer	3.98e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TP53—brain cancer	3.98e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL2—brain cancer	3.97e-06	3.75e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MYC—brain cancer	3.95e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL2—brain cancer	3.95e-06	3.73e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—VEGFA—brain cancer	3.91e-06	3.69e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—VEGFA—brain cancer	3.87e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—VEGFA—brain cancer	3.87e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—STAT3—brain cancer	3.87e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—RELA—brain cancer	3.87e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CCND1—brain cancer	3.87e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—EGFR—brain cancer	3.87e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CCND1—brain cancer	3.85e-06	3.64e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ERBB2—brain cancer	3.84e-06	3.64e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—STAT3—brain cancer	3.83e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—STAT3—brain cancer	3.83e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CTNNB1—brain cancer	3.83e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CTNNB1—brain cancer	3.81e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—RELA—brain cancer	3.81e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—RELA—brain cancer	3.8e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MYC—brain cancer	3.79e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—RELA—brain cancer	3.79e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ERBB2—brain cancer	3.78e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL2—brain cancer	3.78e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ERBB2—brain cancer	3.77e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—RELA—brain cancer	3.77e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ERBB2—brain cancer	3.76e-06	3.56e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CG—brain cancer	3.76e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ERBB2—brain cancer	3.75e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—RELA—brain cancer	3.74e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—RELA—brain cancer	3.73e-06	3.52e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ERBB2—brain cancer	3.71e-06	3.51e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EGFR—brain cancer	3.7e-06	3.5e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ERBB2—brain cancer	3.7e-06	3.5e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCND1—brain cancer	3.68e-06	3.48e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CG—brain cancer	3.67e-06	3.47e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	3.65e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MYC—brain cancer	3.59e-06	3.4e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MYC—brain cancer	3.56e-06	3.37e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MYC—brain cancer	3.56e-06	3.37e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EGFR—brain cancer	3.52e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—brain cancer	3.49e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL2—brain cancer	3.48e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—brain cancer	3.48e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—brain cancer	3.48e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RELA—brain cancer	3.46e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CG—brain cancer	3.45e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—brain cancer	3.44e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ERBB2—brain cancer	3.44e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—brain cancer	3.44e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL2—brain cancer	3.43e-06	3.24e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CG—brain cancer	3.42e-06	3.24e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL2—brain cancer	3.42e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—brain cancer	3.42e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL2—brain cancer	3.41e-06	3.22e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL2—brain cancer	3.4e-06	3.21e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCND1—brain cancer	3.4e-06	3.21e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—brain cancer	3.37e-06	3.19e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL2—brain cancer	3.37e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CTNNB1—brain cancer	3.36e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL2—brain cancer	3.36e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—brain cancer	3.36e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—brain cancer	3.35e-06	3.16e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCND1—brain cancer	3.34e-06	3.16e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—STAT3—brain cancer	3.34e-06	3.16e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCND1—brain cancer	3.33e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCND1—brain cancer	3.32e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—STAT3—brain cancer	3.32e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCND1—brain cancer	3.31e-06	3.13e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CTNNB1—brain cancer	3.31e-06	3.13e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CTNNB1—brain cancer	3.3e-06	3.12e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CTNNB1—brain cancer	3.29e-06	3.11e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CTNNB1—brain cancer	3.28e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCND1—brain cancer	3.28e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCND1—brain cancer	3.27e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CTNNB1—brain cancer	3.25e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—brain cancer	3.25e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	3.24e-06	3.06e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—brain cancer	3.21e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—STAT3—brain cancer	3.18e-06	3.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—brain cancer	3.12e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—brain cancer	3.11e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—brain cancer	3.1e-06	2.93e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—brain cancer	3.09e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—brain cancer	3.04e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—brain cancer	3.04e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—brain cancer	3.02e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	3.01e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—brain cancer	2.96e-06	2.8e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—brain cancer	2.96e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—brain cancer	2.95e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—brain cancer	2.93e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CG—brain cancer	2.93e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—brain cancer	2.92e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—brain cancer	2.92e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—brain cancer	2.91e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—brain cancer	2.91e-06	2.75e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—brain cancer	2.9e-06	2.74e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—brain cancer	2.89e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—brain cancer	2.89e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—brain cancer	2.88e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—brain cancer	2.88e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—brain cancer	2.87e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—brain cancer	2.86e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—brain cancer	2.86e-06	2.7e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—brain cancer	2.85e-06	2.7e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—brain cancer	2.83e-06	2.68e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—brain cancer	2.82e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—brain cancer	2.72e-06	2.58e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—brain cancer	2.68e-06	2.53e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—brain cancer	2.67e-06	2.53e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—brain cancer	2.67e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—brain cancer	2.66e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—brain cancer	2.66e-06	2.51e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—brain cancer	2.65e-06	2.51e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—brain cancer	2.63e-06	2.49e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—brain cancer	2.62e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—brain cancer	2.62e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—brain cancer	2.62e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—brain cancer	2.62e-06	2.47e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—brain cancer	2.61e-06	2.47e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—brain cancer	2.6e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—brain cancer	2.57e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—brain cancer	2.57e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—brain cancer	2.55e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—brain cancer	2.54e-06	2.4e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—brain cancer	2.44e-06	2.31e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—brain cancer	2.43e-06	2.29e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—brain cancer	2.39e-06	2.26e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CG—brain cancer	2.26e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—brain cancer	2.24e-06	2.12e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—brain cancer	2.2e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—brain cancer	2.2e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—brain cancer	2.19e-06	2.07e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—brain cancer	2.18e-06	2.06e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—brain cancer	2.16e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—brain cancer	2.16e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—brain cancer	2e-06	1.89e-05	CbGpPWpGaD
